Published in J Neurosci Res on December 27, 2004
Traumatic brain injury: an overview of pathobiology with emphasis on military populations. J Cereb Blood Flow Metab (2009) 2.12
Ketones inhibit mitochondrial production of reactive oxygen species production following glutamate excitotoxicity by increasing NADH oxidation. Neuroscience (2007) 1.76
Anesthetics isoflurane and desflurane differently affect mitochondrial function, learning, and memory. Ann Neurol (2012) 1.76
Combination therapies for traumatic brain injury: prospective considerations. J Neurotrauma (2009) 1.67
Pharmacology of traumatic brain injury: where is the "golden bullet"? Mol Med (2008) 1.63
Traumatic brain injury: can the consequences be stopped? CMAJ (2008) 1.58
Integrin-FAK signaling rapidly and potently promotes mitochondrial function through STAT3. Cell Commun Signal (2016) 1.38
Mitochondria, oxidative stress, and temporal lobe epilepsy. Epilepsy Res (2009) 1.37
Ketone bodies mediate antiseizure effects through mitochondrial permeability transition. Ann Neurol (2015) 1.34
Mitochondrial mechanisms of cell death and neuroprotection in pediatric ischemic and traumatic brain injury. Exp Neurol (2009) 1.31
The Mitochondrial Permeability Transition Pore: Channel Formation by F-ATP Synthase, Integration in Signal Transduction, and Role in Pathophysiology. Physiol Rev (2015) 1.31
Mechanisms of impaired mitochondrial energy metabolism in acute and chronic neurodegenerative disorders. J Neurosci Res (2007) 1.14
Mitochondrial protection after traumatic brain injury by scavenging lipid peroxyl radicals. J Neurochem (2010) 1.13
Early mitochondrial dysfunction after cortical contusion injury. J Neurotrauma (2009) 1.11
Mitochondria in traumatic brain injury and mitochondrial-targeted multipotential therapeutic strategies. Br J Pharmacol (2012) 1.07
Differential effects of the mitochondrial uncoupling agent, 2,4-dinitrophenol, or the nitroxide antioxidant, Tempol, on synaptic or nonsynaptic mitochondria after spinal cord injury. J Neurosci Res (2009) 1.06
Mitochondrial permeability transition pore is a potential drug target for neurodegeneration. Biochim Biophys Acta (2013) 1.05
Pioglitazone attenuates mitochondrial dysfunction, cognitive impairment, cortical tissue loss, and inflammation following traumatic brain injury. Exp Neurol (2010) 1.04
Methamphetamine- and trauma-induced brain injuries: comparative cellular and molecular neurobiological substrates. Biol Psychiatry (2009) 1.04
Retracted Brain injury following cardiac arrest: pathophysiology for neurocritical care. J Intensive Care (2016) 1.04
Acetyl-L-carnitine ameliorates mitochondrial dysfunction following contusion spinal cord injury. J Neurochem (2010) 1.03
Targeting mitochondrial function for the treatment of acute spinal cord injury. Neurotherapeutics (2011) 1.02
Role of cyclophilin D-dependent mitochondrial permeability transition in glutamate-induced calcium deregulation and excitotoxic neuronal death. Exp Neurol (2009) 1.01
Dosing and safety of cyclosporine in patients with severe brain injury. J Neurosurg (2008) 1.00
Spreading Depression, Spreading Depolarizations, and the Cerebral Vasculature. Physiol Rev (2015) 0.99
Ketones prevent synaptic dysfunction induced by mitochondrial respiratory complex inhibitors. J Neurochem (2010) 0.99
Therapeutic window analysis of the neuroprotective effects of cyclosporine A after traumatic brain injury. J Neurotrauma (2011) 0.98
Influence of aging on membrane permeability transition in brain mitochondria. J Bioenerg Biomembr (2011) 0.96
Safety and tolerability of cyclosporin a in severe traumatic brain injury patients: results from a prospective randomized trial. J Neurotrauma (2009) 0.95
Acetyl-L-carnitine treatment following spinal cord injury improves mitochondrial function correlated with remarkable tissue sparing and functional recovery. Neuroscience (2012) 0.95
The pathophysiology of concussions in youth. Phys Med Rehabil Clin N Am (2011) 0.94
Post-injury administration of the mitochondrial permeability transition pore inhibitor, NIM811, is neuroprotective and improves cognition after traumatic brain injury in rats. J Neurotrauma (2011) 0.94
Mitochondrial proteomics in experimental autoimmune uveitis oxidative stress. Invest Ophthalmol Vis Sci (2009) 0.93
The functional and neuroprotective actions of Neu2000, a dual-acting pharmacological agent, in the treatment of acute spinal cord injury. J Neurotrauma (2010) 0.93
Brain metabolism is significantly impaired at blood glucose below 6 mM and brain glucose below 1 mM in patients with severe traumatic brain injury. Crit Care (2010) 0.93
Pathophysiology of sports-related concussion: an update on basic science and translational research. Sports Health (2011) 0.92
Perspectives on molecular biomarkers of oxidative stress and antioxidant strategies in traumatic brain injury. Biomed Res Int (2014) 0.91
Focal cerebral ischemia and mitochondrial dysfunction in the TNFα-transgenic rat. Brain Res (2011) 0.91
The injured nervous system: a Darwinian perspective. Prog Neurobiol (2008) 0.90
MicroRNAs: Key Regulators in the Central Nervous System and Their Implication in Neurological Diseases. Int J Mol Sci (2016) 0.87
Isolation of mitochondria from the CNS. Curr Protoc Neurosci (2010) 0.87
Concentration dependent effect of calcium on brain mitochondrial bioenergetics and oxidative stress parameters. Front Neuroenergetics (2013) 0.86
Role of oxidative stress and the mitochondrial permeability transition in methylmercury cytotoxicity. Neurotoxicology (2011) 0.86
Emerging therapies in traumatic brain injury. Semin Neurol (2015) 0.86
N-acetylcysteine amide confers neuroprotection, improves bioenergetics and behavioral outcome following TBI. Exp Neurol (2014) 0.85
Phenelzine mitochondrial functional preservation and neuroprotection after traumatic brain injury related to scavenging of the lipid peroxidation-derived aldehyde 4-hydroxy-2-nonenal. J Cereb Blood Flow Metab (2013) 0.85
Neuroprotective effects of N-acetyl-cysteine and acetyl-L-carnitine after spinal cord injury in adult rats. PLoS One (2012) 0.85
A time course of NADPH-oxidase up-regulation and endothelial nitric oxide synthase activation in the hippocampus following neurotrauma. Free Radic Biol Med (2014) 0.84
Neuroproteomics: a biochemical means to discriminate the extent and modality of brain injury. J Neurotrauma (2010) 0.84
Duration of ATP reduction affects extent of CA1 cell death in rat models of fluid percussion injury combined with secondary ischemia. Brain Res (2008) 0.83
Probing the molecular mechanisms of neuronal degeneration: importance of mitochondrial dysfunction and calcineurin activation. J Anesth (2008) 0.83
Reperfusion promotes mitochondrial biogenesis following focal cerebral ischemia in rats. PLoS One (2014) 0.83
Lipid peroxidation in brain or spinal cord mitochondria after injury. J Bioenerg Biomembr (2016) 0.83
Mitochondria-Targeted Peptide Reverses Mitochondrial Dysfunction and Cognitive Deficits in Sepsis-Associated Encephalopathy. Mol Neurobiol (2014) 0.82
Effect of cyclosporin A on functional recovery in the spinal cord following contusion injury. J Anat (2009) 0.82
Cellular alterations in human traumatic brain injury: changes in mitochondrial morphology reflect regional levels of injury severity. J Neurotrauma (2013) 0.82
Dietary Omega-3 Fatty Acids Do Not Change Resistance of Rat Brain or Liver Mitochondria to Ca(2+) and/or Prooxidants. J Lipids (2012) 0.81
Mitochondria, Amyloid β, and Alzheimer's Disease. Int J Alzheimers Dis (2011) 0.81
Establishing a Clinically Relevant Large Animal Model Platform for TBI Therapy Development: Using Cyclosporin A as a Case Study. Brain Pathol (2015) 0.81
Chronic treatment with anesthetic propofol improves cognitive function and attenuates caspase activation in both aged and Alzheimer's disease transgenic mice. J Alzheimers Dis (2014) 0.80
Ethanol withdrawal provokes mitochondrial injury in an estrogen preventable manner. J Bioenerg Biomembr (2008) 0.80
Broad-spectrum neuroprotection against traumatic brain injury by agonism of peroxisome proliferator-activated receptors. Exp Neurol (2011) 0.80
Role of calcium and mitochondria in MeHg-mediated cytotoxicity. J Biomed Biotechnol (2012) 0.80
Cyclosporine A, FK506, and NIM811 ameliorate prolonged CBF reduction and impaired neurovascular coupling after cortical spreading depression. J Cereb Blood Flow Metab (2011) 0.80
Cellular and subcellular oxidative stress parameters following severe spinal cord injury. Redox Biol (2015) 0.79
Ethanol withdrawal provokes opening of the mitochondrial membrane permeability transition pore in an estrogen-preventable manner. J Pharmacol Exp Ther (2008) 0.79
Role of Glia in Memory Deficits Following Traumatic Brain Injury: Biomarkers of Glia Dysfunction. Front Integr Neurosci (2016) 0.79
Exacerbation of apoptosis of cortical neurons following traumatic brain injury in par-4 transgenic mice. Int J Clin Exp Pathol (2008) 0.78
Differences between dextroamphetamine and methamphetamine: behavioral changes and oxidative damage in brain of Wistar rats. J Neural Transm (Vienna) (2011) 0.78
Dietary fructose aggravates the pathobiology of traumatic brain injury by influencing energy homeostasis and plasticity. J Cereb Blood Flow Metab (2015) 0.77
Glucose administration after traumatic brain injury exerts some benefits and no adverse effects on behavioral and histological outcomes. Brain Res (2015) 0.77
Progesterone protects mitochondrial function in a rat model of pediatric traumatic brain injury. J Bioenerg Biomembr (2014) 0.77
Role of mitochondria in regulating microRNA activity and its relevance to the central nervous system. Neural Regen Res (2015) 0.76
Battery of behavioral tests in mice to study postoperative delirium. Sci Rep (2016) 0.76
Neuronal Cell Death Induced by Mechanical Percussion Trauma in Cultured Neurons is not Preceded by Alterations in Glucose, Lactate and Glutamine Metabolism. Neurochem Res (2016) 0.76
Omega-3 Fatty acids could alleviate the risks of traumatic brain injury - a mini review. J Tradit Complement Med (2014) 0.76
Hydroxysafflor yellow A exerts antioxidant effects in a rat model of traumatic brain injury. Mol Med Rep (2016) 0.76
Brain-on-a-chip microsystem for investigating traumatic brain injury: Axon diameter and mitochondrial membrane changes play a significant role in axonal response to strain injuries. Technology (Singap World Sci) (2014) 0.75
Synaptic Mitochondria Sustain More Damage than Non-Synaptic Mitochondria after Traumatic Brain Injury and Are Protected by Cyclosporine A. J Neurotrauma (2016) 0.75
Preparation of purified perikaryal and synaptosomal mitochondrial fractions from relatively small hypothalamic brain samples. MethodsX (2016) 0.75
Phenelzine Protects Brain Mitochondrial Function In Vitro and In Vivo following Traumatic Brain Injury by Scavenging the Reactive Carbonyls 4-Hydroxynonenal and Acrolein Leading to Cortical Histological Neuroprotection. J Neurotrauma (2016) 0.75
Variation in PPP3CC Genotype Is Associated with Long-Term Recovery after Severe Brain Injury. J Neurotrauma (2016) 0.75
Thioredoxin-Mimetic-Peptides Protect Cognitive Function after Mild Traumatic Brain Injury (mTBI). PLoS One (2016) 0.75
Targeting mitochondrial dysfunction in CNS injury using Methylene Blue; still a magic bullet? Neurochem Int (2017) 0.75
Pioglitazone treatment following spinal cord injury maintains acute mitochondrial integrity and increases chronic tissue sparing and functional recovery. Exp Neurol (2017) 0.75
Optimization of Mitochondrial Isolation Techniques for Intraspinal Transplantation Procedures. J Neurosci Methods (2017) 0.75
Acute inflammatory response in spinal cord following impact injury. Exp Neurol (1998) 1.87
Exacerbation of damage and altered NF-kappaB activation in mice lacking tumor necrosis factor receptors after traumatic brain injury. J Neurosci (1999) 1.55
Impaired mitochondrial function, oxidative stress and altered antioxidant enzyme activities following traumatic spinal cord injury. Brain Res (1997) 1.35
Riluzole increases high-affinity glutamate uptake in rat spinal cord synaptosomes. Brain Res (2000) 1.29
On the relevance of preferential increases of mesolimbic versus striatal dopamine turnover for the prediction of antipsychotic activity of psychotropic drugs. J Neurochem (1976) 1.18
Transgenic activation of Ras in neurons promotes hypertrophy and protects from lesion-induced degeneration. J Cell Biol (2000) 1.08
Dose-response curve and optimal dosing regimen of cyclosporin A after traumatic brain injury in rats. Neuroscience (2000) 1.08
ALS-linked Cu/Zn-SOD mutation increases vulnerability of motor neurons to excitotoxicity by a mechanism involving increased oxidative stress and perturbed calcium homeostasis. Exp Neurol (1999) 1.07
NIM811, a mitochondrial permeability transition inhibitor, prevents mitochondrial depolarization in small-for-size rat liver grafts. Am J Transplant (2007) 1.07
Attenuation of acute mitochondrial dysfunction after traumatic brain injury in mice by NIM811, a non-immunosuppressive cyclosporin A analog. Exp Neurol (2007) 1.04
Localization of glial cell line-derived neurotrophic factor receptor alpha and c-ret mRNA in rat central nervous system. J Comp Neurol (1998) 1.02
Methylhistamine: evidence for selective deamination by MAO B in the rat brain in vivo. J Neurochem (1977) 1.02
Altered expression of bcl-2 and bax mRNA in amyotrophic lateral sclerosis spinal cord motor neurons. Ann Neurol (1996) 1.01
Demonstration of the retrograde transport of nerve growth factor receptor in the peripheral and central nervous system. J Neurosci (1987) 0.98
Effects of clomipramine and other tricyclic antidepressants on biogenic amine uptake and turnover. Postgrad Med J (1976) 0.98
Further evidence for negative feedback control of serotonin release in the central nervous system. Naunyn Schmiedebergs Arch Pharmacol (1981) 0.97
Preferential deamination of dopamine by an A type monoamine oxidase in rat brain. Naunyn Schmiedebergs Arch Pharmacol (1976) 0.97
An orally active anti-apoptotic molecule (CGP 3466B) preserves mitochondria and enhances survival in an animal model of motoneuron disease. Br J Pharmacol (2000) 0.96
Acetyl-L-carnitine treatment following spinal cord injury improves mitochondrial function correlated with remarkable tissue sparing and functional recovery. Neuroscience (2012) 0.95
Spinal cord motoneurons express p75NGFR and p145trkB mRNA in amyotrophic lateral sclerosis. Brain Res (1993) 0.95
Amine oxidases and their endogenous substrates (with special reference to monoamine oxidase and the brain). J Neural Transm Suppl (1987) 0.93
Riluzole improves measures of oxidative stress following traumatic spinal cord injury. Brain Res (2000) 0.93
The effects of 5-HT uptake- and MAO-inhibitors on L-5-HTP-induced excitation in rats. Naunyn Schmiedebergs Arch Pharmacol (1980) 0.93
Overexpression of GDNF induces and maintains hyperinnervation of muscle fibers and multiple end-plate formation. Exp Neurol (2001) 0.92
Intraspinal sprouting of unmyelinated pelvic afferents after complete spinal cord injury is correlated with autonomic dysreflexia induced by visceral pain. Neuroscience (2008) 0.92
Alteration of central alpha 2- and beta-adrenergic receptors in the rat after DSP-4, a selective noradrenergic neurotoxin. Neuroscience (1983) 0.91
Serotonin--dopamine interactions in the nigrostriatal system. Eur J Pharmacol (1979) 0.91
FAC1 expression and localization in motor neurons of developing, adult, and amyotrophic lateral sclerosis spinal cord. Exp Neurol (1997) 0.91
BDNF and NT4/5 promote survival and neurite outgrowth of pontocerebellar mossy fiber neurons. J Neurobiol (1999) 0.90
Investigations on GABAB receptor-mediated autoinhibition of GABA release. Naunyn Schmiedebergs Arch Pharmacol (1990) 0.88
Experimental rationale for the therapeutic use of neurotrophins in amyotrophic lateral sclerosis. Exp Neurol (1993) 0.86
Effects of baclofen on dopamine metabolism and interaction with neuroleptic effects. Eur J Pharmacol (1978) 0.86
Selective inhibition of noradrenaline and serotonin uptake by C 49802-B-Ba and CGP 6085 A. Eur J Pharmacol (1977) 0.85
Riluzole and methylprednisolone combined treatment improves functional recovery in traumatic spinal cord injury. J Neurotrauma (2000) 0.85
Cumulative effects of irreversible MAO inhibitors in vivo. Biochem Pharmacol (1979) 0.84
Effects of baclofen and gamma-hydroxybutyrate on rat striatal and mesolimbic 5-HT metabolism. Eur J Pharmacol (1978) 0.84
On the reversibility of reversible MAO inhibitors. Naunyn Schmiedebergs Arch Pharmacol (1985) 0.82
Effects of antidepressant drugs on dopamine uptake and metabolism. J Pharm Pharmacol (1982) 0.82
Basal forebrain magnocellular neurons stain for nerve growth factor receptor: correlation with cholinergic cell bodies and effects of axotomy. J Neurosci Res (1987) 0.82
Radiosynthesis of [11C]brofaromine, a potential tracer for imaging monoamine oxidase A. Nucl Med Biol (1996) 0.82
Regional analysis of age-related changes in the cholinergic system of the hippocampal formation and basal forebrain of the rat. Brain Res (1987) 0.82
Negative feedback control of serotonin release in vivo: comparison of 5-hydroxyindolacetic acid levels measured by voltammetry in conscious rats and by biochemical techniques. Neuroscience (1984) 0.81
Amine uptake inhibitors: criteria of selectivity. Acta Psychiatr Scand Suppl (1980) 0.81
Activation of NMDA receptors increases brain-derived neurotrophic factor (BDNF) mRNA expression in the hippocampal formation. Neuroreport (1993) 0.81
Intrahippocampal injections of antiserum to nerve growth factor inhibit sympathohippocampal sprouting. Brain Res Bull (1985) 0.81
Stimulation of central serotonin turnover by beta-adrenoceptor agonists. Naunyn Schmiedebergs Arch Pharmacol (1981) 0.81
Is there a common denominator for the antimanic effect of lithium and anticonvulsants? Pharmacopsychiatry (1987) 0.80
Central nervous system grafts of nerve growth factor-rich tissue as an alternative source of trophic support for axotomized cholinergic neurons. Prog Brain Res (1988) 0.80
Deprenil: loss of selectivity for inhibition of B-type MAO after repeated treatment. Biochem Pharmacol (1978) 0.80
Oxaprotiline, a noradrenaline uptake inhibitor with an active and an inactive enantiomer. Biochem Pharmacol (1982) 0.80
Diffusible factor(s) from adult rat sciatic nerve increases cell number and neurite outgrowth of cultured embryonic ventral mesencephalic tyrosine hydroxylase-positive neurons. J Neurosci Res (1990) 0.79
Clozapine: reduction of the initial dopamine turnover increase by repeated treatment. Eur J Pharmacol (1976) 0.79
Suppression of corticosterone synthesis alters the behavior of hippocampally lesioned rats. Behav Neural Biol (1985) 0.78
Determination of rat brain and plasma levels of the orally active GABAB antagonist 3-amino-propyl-n-butyl-phosphinic acid (CGP 36742) by a new GC/MS method. Biochem Pharmacol (1996) 0.78
Differentiation of basal ganglia dopaminergic involvement in behavior after hippocampectomy. Brain Res (1984) 0.78
On the role of O-methylation in the metabolism of S-adenosylmethionine in rat brain. Biochem Pharmacol (1987) 0.78
Co-grafts of embryonic dopamine neurons and adult sciatic nerve into the denervated striatum enhance behavioral and morphological recovery in rats. Exp Neurol (1991) 0.77
Determination of 2-phenylethylamine in rat brain after MAO inhibitors, and in human CSF and urine by capillary GC and chemical ionization MS. J Neural Transm (1984) 0.77
The monoamine oxidase inhibiting properties of CGP 11305 A. Eur J Pharmacol (1983) 0.77
Regulation of nerve growth factor mRNA in the hippocampal formation effects of N-methyl-D-aspartate receptor activation. Exp Neurol (1993) 0.77
Endogenous glutamate levels regulate nerve growth factor mRNA expression in the rat dentate gyrus. Mol Cells (1997) 0.77
Noradrenergic transmission in depression: under- or overfunction? Pharmacopsychiatria (1981) 0.77
Effect of maprotiline, a new antidepressant drug, on serotonin uptake. Adv Biochem Psychopharmacol (1974) 0.77
Phenylethylamine-induced stereotypies in the rat: a behavioral test system for assessment of MAO-B inhibitors. Psychopharmacology (Berl) (1984) 0.77
3-Methoxytyramine: its suitability as an indicator of synaptic dopamine release. Naunyn Schmiedebergs Arch Pharmacol (1981) 0.77
Hyperthermic preconditioning protects against spinal cord ischemic injury. Ann Thorac Surg (2000) 0.77
CGP 6085 A, a new, specific, inhibitor of serotonin uptake: neurochemical characterization and comparison with other serotonin uptake blockers. J Pharmacol Exp Ther (1979) 0.77
Urinary excretion of O-methylated catecholamines, tyramine and phenyl-ethylamine by volunteers treated with tranylcypromine and CGP 11305 A. Eur J Clin Pharmacol (1983) 0.76
The inhibition of monoamine oxidase by brofaromine. Biochem Pharmacol (1991) 0.76
Increased dopamine metabolism in rat striatum after infusions of substance P into the substantia nigra. Brain Res (1978) 0.76
Brofaromine--a review of its pharmacological properties and therapeutic use. J Neural Transm (Vienna) (1996) 0.76
Analysis of the activation of dopamine metabolism by a serotonin uptake inhibitor. Eur J Pharmacol (1979) 0.76
Behavioral assessment of norepinephrine and serotonin function and interaction in the hippocampal formation. Pharmacol Biochem Behav (1981) 0.76
Displacement of striatal 5-hydroxytryptamine by dopamine released from endogenous stores. J Pharm Pharmacol (1985) 0.76
Effects of CGP 11305 A, a new reversible and selective inhibitor of MAO A, on biogenic amine levels and metabolism in the rat brain. Naunyn Schmiedebergs Arch Pharmacol (1983) 0.76
Discrimination of neuroleptics by means of their interaction with amfonelic acid: an attempt to characterize the test. Biochem Pharmacol (1985) 0.75
Comparison of short and long-lasting effects of pargyline on cerebral dopamine metabolism. Naunyn Schmiedebergs Arch Pharmacol (1976) 0.75
Basic and clinical aspects of the activity of the new monoamine oxidase inhibitors. Psychopharmacol Ser (1988) 0.75
Experimental evidence for growth factor treatment and function in certain neurological disorders. Exp Neurol (1993) 0.75
Neurochemical investigations of the interaction of N,N-dimethyltryptamine with dopaminergic system in rat brain. Psychopharmacology (Berl) (1977) 0.75
Comparison of the effects of maprotiline (ludiomil) and clomipramine (anafranil) on serotonin uptake and tryptophan-binding in plasma. Biol Psychiatry (1976) 0.75
CGP 4718 A, a new potential antidepressant with a dual mode of action. Eur J Pharmacol (1984) 0.75
Proceedings: Lack of significance of MAO-B for in vivo deamination of dopamine. Naunyn Schmiedebergs Arch Pharmacol (1975) 0.75
Catecholamine alterations in basal ganglia after hippocampal lesions. Brain Res (1982) 0.75
Ifoxetine, a compound with atypical effects on serotonin uptake. Eur J Pharmacol (1986) 0.75
Clinical pharmacology of the new COMT inhibitor CGP 28,014. Neurochem Res (1993) 0.75
The use of scopolamine for the estimation of the central antiacetylcholine properties of neuroleptics. J Pharm Pharmacol (1979) 0.75
Neurotrophic factor mRNA expression in dentate gyrus is increased following angular bundle transection. Brain Res (1994) 0.75
AMINE UPTAKE INHIBITORS: CRITERIA OF SELECTIVITY. Acta Psychiatr Scand (1980) 0.75
Neural graft augmentation through co-grafting: implantation of cells as sources of survival and growth factors. Prog Neurobiol (1994) 0.75
Glutamate-induced activation of rat locus coeruleus increases CA1 pyramidal cell excitability. Neurosci Lett (1986) 0.75
5-HT uptake inhibitors: psychopharmacological and neurobiochemical criteria of selectivity. Adv Biochem Psychopharmacol (1982) 0.75
Metaraminol uptake by human thrombocytes: a poor model for neuronal noradrenaline uptake. Experientia (1977) 0.75
Inhibition and activation of enzymatic transfer of the methyl group from 5-methyltetrahydrofolate to tryptamine by catecholamine metabolites and analogues. Biochem Pharmacol (1975) 0.75
Morpholin-2-yl-phosphinic acids are potent GABA(B) receptor antagonists in rat brain. Eur J Pharmacol (1998) 0.75
Serotoninergic modulation of mesolimbic and frontal cortical dopamine neurons. Experientia (1980) 0.75
A role for computer simulation in solving the riddles of autoreceptor-mediated regulation of GABA release. Naunyn Schmiedebergs Arch Pharmacol (1993) 0.75
Experimentally induced supersensitivity of neocortical neurons to microiontophoretically administered serotonin. Brain Res (1981) 0.75
Neutralization tests of infectious pancreatic necrosis virus with polyvalent antiserum. J Wildl Dis (1973) 0.75
Supersensitivity to L-5-hydroxytryptophan after 5,7-dihydroxytryptamine injections in desmethylimipramine- and nomifensine-pretreated rats: behavioral evidence for postsynaptic supersensitivity. Psychopharmacology (Berl) (1981) 0.75